Pomerantz LLP

Please review this complaint. Click to Contact Us about joining this ACTION >>

Questions? Ask Us

Curaleaf Holdings, Inc.

We are investigating Curaleaf Holdings, Inc. (CURLF) (“Curaleaf” or the “Company”) for potential violations of the federal securities laws. 

On July 22, 2019, the U.S. Food & Drug Administration sent a warning letter to Curaleaf stating that several of the cannabidiol products sold on the Company’s website were “misbranded drugs” in violation of the Federal Food, Drug, and Cosmetic Act.  On this news, Curaleaf’s stock price fell $0.58 per share, or 7.27%, to close at $7.40 per share on July 23, 2019.